Company Filing History:

15 out of 6,662

Hoechst Aktiengesellschaft

patents

5 out of 18

Hoechst Marion Roussel Deutschland Gmbh

patents

1 out of 330

Aventis Pharma Deutschland, Gmbh

patents

4. 1 out of 1

Hoechst Aketiengesellschaft

patent

Years Active: 1989-2001

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6184221 - Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them (2001-02-06),

2. 6177449 - Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them (2001-01-23),

3. 6093730 - Substituted isoquinoline-3-carboxamides, their preparation and their use (2000-07-25),

4. 6087399 - Sulfonamide-substituted compounds, process for their preparation, their (2000-07-11),

5. 6071953 - Sulfonamide-substituted chromans, processes for their preparation, their (2000-06-06),

6. 6020350 - 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use (2000-02-01),

7. 6015822 - Sulfonamide-substituted fused 5-membered ring compounds, their use as a (2000-01-18),

8. 6008245 - Sulfonamide-substituted benzopyran derivatives, processes for their (1999-12-28),

9. 5955607 - Sulfonamide-substituted chromans, processes for their preparation, their (1999-09-21),

10. 5856338 - Sulfonamide-substituted compounds, processes for their preparation, (1999-01-05),

11. 5726305 - Substituted quinoline-2-carboxamides, their preparation and their use as (1998-03-10),

12. 5719164 - Substituted quinoline-2-carboxamides, their preparation and their use as (1998-02-17),

13. 5658933 - Substituted heterocyclic carboxamide esters, their preparation and their (1997-08-19),

14. 5620996 - Sulfonamidocarbonyl pyridine-2-carboxesteramides and their (1997-04-15),

15. 5620995 - Substituted heterocyclic carboxyamides, their preparation and their use (1997-04-15),

Title: Innovations and Contributions of Klaus Weidmann

Introduction

Klaus Weidmann, a prominent inventor based in Kronberg, Germany, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 22 patents, his work focuses on developing novel compounds that have potential applications in medicine.

Latest Patents

Among his latest innovations are patents related to sulfonamide-substituted compounds. He has developed processes for their preparation and explored their use as medicaments or diagnostics. These patents include compounds of formula I, underscoring his dedication to advancing pharmaceutical science. Additionally, his research extends to sulfonamide-substituted chromans, where he has outlined processes for their preparation and their applications in the medical field, including pharmaceutical preparations comprising these compounds.

Career Highlights

Klaus Weidmann's career features significant roles in reputable companies such as Hoechst Aktiengesellschaft and Hoechst Marion Roussel Deutschland GmbH. His tenure at these organizations has been marked by a commitment to innovation and excellence in the pharmaceutical industry.

Collaborations

Throughout his career, Klaus has collaborated with esteemed professionals in the field, including Martin Bickel and Joachim Brendel. These partnerships have enriched his research and contributed to his success as an inventor, fostering a collaborative environment that promotes the development of cutting-edge medicinal technologies.

Conclusion

Klaus Weidmann continues to be an influential figure in the pharmaceutical industry. His dedication to developing new medicinal compounds through innovative processes reflects his commitment to improving health outcomes. With numerous patents to his name, his contributions are shaping the future of medicinal chemistry and diagnostics.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com